Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00395031
Previous Study | Return to List | Next Study

Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00395031
Recruitment Status : Completed
First Posted : November 2, 2006
Last Update Posted : July 29, 2011
Sponsor:
Collaborator:
Pfizer
Information provided by:
Manhattan Psychiatric Center

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : January 2010
Actual Study Completion Date : January 2010
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 25, 2014
October 29, 2014
2 April 10, 2015
April 28, 2015
3 September 29, 2020
October 1, 2020